Internet Archive Scholar

Prognostic Value of Combined Detection of Serum and Pleural Fluid Tumor Markers in Non-small Cell Lung Cancer With Malignant Pleural Effusion [post]

Li-Xu Xie, Shi-Chang Jiang, Zi Chen, Shu-Juan Jiang, Xing-Guang Wang, Lin-Fu Zhou
2020 unpublished

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (615.8 kB)
https://web.archive.org/web/20201103060041/https://assets.researchsquare.com/files/rs-35527/v1/a4e54c20-3277-41c7-ba85-601eceac09fa.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

Background: Serum tumor markers are considered a negative prognostic factor in non-small cell lung cancer (NSCLC). Combined detection of serum and pleural fluid (PF) tumor markers is rarely reported. The aim of this study was to analyze the relationship between combined detection of serum and pleural fluid (SPF) tumor markers and prognosis in advanced NSCLC.Results: High levels of SPF CEA (P = 0.001) , SPF CYFRA21-1 (P = 0.001) and SPF CA-125 (P = 0.023) were adversely prognostic factors for
more » ... rall survival (OS). High levels of SPF CEA (P = 0.003) , SPF CYFRA21-1 (P = 0.001) and SPF NSE (P = 0.019) were related to worse progression-free survival (PFS). In multivariate analysis high levels of SPF CYFRA21-1 was a independent predictor of OS and high levels of SPF CEA and SPF CYFRA21-1 were independent predictors of PFS.Conclusions: High levels of SPF CEA and SPF CYFRA21-1 are correlated with worse survival in advanced NSCLC patients with MPE. The identification of prognostic factors maybe useful in stratifying high-risk populations and will assist the choice of treatment planning.
doi:10.21203/rs.3.rs-35527/v1 fatcat:v55dtjtmzna37fqwvqfewsiiru
Open Access
Citation

Li-Xu Xie, Shi-Chang Jiang, Zi Chen, Shu-Juan Jiang, Xing-Guang Wang, Lin-Fu Zhou. "Prognostic Value of Combined Detection of Serum and Pleural Fluid Tumor Markers in Non-small Cell Lung Cancer With Malignant Pleural Effusion." (2020)